This strain contains 49 protein-level mutations:
We identified all possible linear viral peptides affected by these mutations. Whenever it was possible, we matched the reference peptide with the mutated one. For example, D -> L mutation transformed SDNGPQNQR to SLNGPQNQR. Cases when it was not meaningful included deletions and insertions at the flanks of the peptide, e.g., HV deletion in NVTWFHAIHV peptide.
Then, we predicted binding affinities between the selected peptides and frequent HLA alleles. Predictions were made with NetMHCpan-4.1 and NetMHCIIpan-4.0. The binding affinities were classifies into three groups:
Here we report HLA-peptide interactions whose affinity was altered by at least two folds. Note that mutations with empty set of altered interactions are not showed.
Weaker binding was found for 3 epitopes, while stronger binding was found for 4 entries. There are 11 tight binders for the HLA-C*07:02 in the reference immunopeptidome (IC50 affinity ≤ 50 nM); 0 of them became non-tight binders (0.0%) and 0 novel tight binders appeared (0.0%). To avoid possible divisions by zero, we used + 1 regularization term in denominators when calculating percentages.
Reference YQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPAT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated YQAGNKPCNGVAGVNCYFPLQSYGFRPTYGVGHQPYRVVVLSFELLHAPAT
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*07:02 | FQPTNGVGYQPY | FRPTYGVGHQPY | 6169 | 356 |
Reference GSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCG
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated GNKPCNGVAGVNCYFPLQSYGFRPTYGVGHQPYRVVVLSFELLHAPATVCG
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*07:02 | FQPTNGVGYQPY | FRPTYGVGHQPY | 6169 | 356 |
Reference CNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKS
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CNGVAGVNCYFPLQSYGFRPTYGVGHQPYRVVVLSFELLHAPATVCGPKKS
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*07:02 | FQPTNGVGYQPY | FRPTYGVGHQPY | 6169 | 356 |
HLA-C*07:02 | YQPYRVVVL | HQPYRVVVL | 135 | 590 |
Reference AVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDL
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated AVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDL
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*07:02 | YKTPPIKDF | YKTPPIKYF | 1804 | 378 |
Reference QPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCV
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated QPGQTFSVLACYNGSPSGVYQCAMRHNFTIKGSFLNGSCGSVGFNIDYDCV
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*07:02 | MRPNFTIKGSF | MRHNFTIKGSF | 361 | 1054 |
Reference TADIVVFDEISMATNYDLSVVNARLRAKHYVYIGDPAQLPAPRTLLTKGTL
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated TADIVVFDEISMATNYDLSVVNARLCAKHYVYIGDPAQLPAPRTLLTKGTL
Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
---|---|---|---|---|
HLA-C*07:02 | LRAKHYVYI | LCAKHYVYI | 433 | 17614 |